Log in to save to my catalogue

Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hams...

Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hams...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_417894952ca54f88947455ec8d336df7

Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Safe and effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are crucial to fight against the coronavirus disease 2019 pandemic. Most vaccines are based on a mutated version of the Spike glycoprotein [K986P/V987P (S-2P)] with improved stability, yield and immunogenicity. However, S-2P is still produced at low levels. Her...

Alternative Titles

Full title

Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_417894952ca54f88947455ec8d336df7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_417894952ca54f88947455ec8d336df7

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-024-46714-w

How to access this item